CN109152541A - 使用脉管内压力测量和外部超声成像来确定脉搏波速度以及相关联的设备、系统和方法 - Google Patents
使用脉管内压力测量和外部超声成像来确定脉搏波速度以及相关联的设备、系统和方法 Download PDFInfo
- Publication number
- CN109152541A CN109152541A CN201780031122.9A CN201780031122A CN109152541A CN 109152541 A CN109152541 A CN 109152541A CN 201780031122 A CN201780031122 A CN 201780031122A CN 109152541 A CN109152541 A CN 109152541A
- Authority
- CN
- China
- Prior art keywords
- vascular
- pressure
- equipment
- data
- processing system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 67
- 210000003462 vein Anatomy 0.000 title claims abstract description 15
- 210000001367 artery Anatomy 0.000 title claims abstract description 14
- 238000005259 measurement Methods 0.000 title abstract description 9
- 238000012285 ultrasound imaging Methods 0.000 title abstract description 3
- 230000002792 vascular Effects 0.000 claims abstract description 310
- 238000003384 imaging method Methods 0.000 claims abstract description 134
- 238000012545 processing Methods 0.000 claims abstract description 125
- 239000012530 fluid Substances 0.000 claims abstract description 59
- 238000002604 ultrasonography Methods 0.000 claims abstract description 54
- 238000012544 monitoring process Methods 0.000 claims abstract description 35
- 238000007493 shaping process Methods 0.000 claims abstract description 8
- 230000001360 synchronised effect Effects 0.000 claims abstract description 7
- 210000003734 kidney Anatomy 0.000 claims description 94
- 230000002638 denervation Effects 0.000 claims description 36
- 230000008901 benefit Effects 0.000 claims description 12
- 230000000007 visual effect Effects 0.000 claims description 6
- 210000005036 nerve Anatomy 0.000 description 29
- 230000002889 sympathetic effect Effects 0.000 description 25
- 206010020772 Hypertension Diseases 0.000 description 22
- 210000002216 heart Anatomy 0.000 description 21
- 230000036772 blood pressure Effects 0.000 description 16
- 210000004204 blood vessel Anatomy 0.000 description 15
- 230000000747 cardiac effect Effects 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 238000010586 diagram Methods 0.000 description 11
- 239000000523 sample Substances 0.000 description 11
- 230000006870 function Effects 0.000 description 10
- 230000009467 reduction Effects 0.000 description 10
- 210000003484 anatomy Anatomy 0.000 description 9
- 210000002254 renal artery Anatomy 0.000 description 9
- 230000004913 activation Effects 0.000 description 8
- 210000004556 brain Anatomy 0.000 description 8
- 208000020832 chronic kidney disease Diseases 0.000 description 8
- 229940088597 hormone Drugs 0.000 description 8
- 239000005556 hormone Substances 0.000 description 8
- 230000008035 nerve activity Effects 0.000 description 8
- 230000008569 process Effects 0.000 description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- 238000004891 communication Methods 0.000 description 6
- 210000000653 nervous system Anatomy 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 241001269238 Data Species 0.000 description 5
- 102100028255 Renin Human genes 0.000 description 5
- 108090000783 Renin Proteins 0.000 description 5
- 238000009530 blood pressure measurement Methods 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 230000000638 stimulation Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 206010007558 Cardiac failure chronic Diseases 0.000 description 4
- 206010041277 Sodium retention Diseases 0.000 description 4
- 210000000702 aorta abdominal Anatomy 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 4
- 230000002093 peripheral effect Effects 0.000 description 4
- 208000015658 resistant hypertension Diseases 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- 210000005166 vasculature Anatomy 0.000 description 4
- 206010019280 Heart failures Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000013480 data collection Methods 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 230000005611 electricity Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000000004 hemodynamic effect Effects 0.000 description 3
- 230000001631 hypertensive effect Effects 0.000 description 3
- 230000003907 kidney function Effects 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 3
- 230000008700 sympathetic activation Effects 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 206010022489 Insulin Resistance Diseases 0.000 description 2
- 229920002614 Polyether block amide Polymers 0.000 description 2
- 208000001647 Renal Insufficiency Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 210000000709 aorta Anatomy 0.000 description 2
- 238000010009 beating Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 201000006370 kidney failure Diseases 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 210000004179 neuropil Anatomy 0.000 description 2
- 230000010412 perfusion Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 230000035485 pulse pressure Effects 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 238000000718 qrs complex Methods 0.000 description 2
- 238000010010 raising Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 235000021023 sodium intake Nutrition 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- 102000015427 Angiotensins Human genes 0.000 description 1
- 108010064733 Angiotensins Proteins 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003084 Areflexia Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000021479 Cardiovascular injury Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000003098 Ganglion Cysts Diseases 0.000 description 1
- 102100025283 Gap junction alpha-8 protein Human genes 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 208000007177 Left Ventricular Hypertrophy Diseases 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010063897 Renal ischaemia Diseases 0.000 description 1
- 206010049418 Sudden Cardiac Death Diseases 0.000 description 1
- 208000005400 Synovial Cyst Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000004079 adrenergic fiber Anatomy 0.000 description 1
- 229960002478 aldosterone Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 210000000467 autonomic pathway Anatomy 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 208000028208 end stage renal disease Diseases 0.000 description 1
- 201000000523 end stage renal failure Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000000574 ganglionic effect Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000005182 global health Effects 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 210000002837 heart atrium Anatomy 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000007383 nerve stimulation Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 239000000712 neurohormone Substances 0.000 description 1
- 230000004007 neuromodulation Effects 0.000 description 1
- 102000008434 neuropeptide hormone activity proteins Human genes 0.000 description 1
- 108040002669 neuropeptide hormone activity proteins Proteins 0.000 description 1
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000012946 outsourcing Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 238000005424 photoluminescence Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- -1 polytetrafluoroethylene Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000003087 receptor blocking agent Substances 0.000 description 1
- 230000008085 renal dysfunction Effects 0.000 description 1
- 210000002796 renal vein Anatomy 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 201000002859 sleep apnea Diseases 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- CCEKAJIANROZEO-UHFFFAOYSA-N sulfluramid Chemical group CCNS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F CCEKAJIANROZEO-UHFFFAOYSA-N 0.000 description 1
- 210000000331 sympathetic ganglia Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/026—Measuring blood flow
- A61B5/0285—Measuring or recording phase velocity of blood waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/02007—Evaluating blood vessel condition, e.g. elasticity, compliance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/02108—Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/0215—Measuring pressure in heart or blood vessels by means inserted into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/20—Measuring for diagnostic purposes; Identification of persons for measuring urological functions restricted to the evaluation of the urinary system
- A61B5/201—Assessing renal or kidney functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7239—Details of waveform analysis using differentiation including higher order derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient; User input means
- A61B5/742—Details of notification to user or communication with user or patient; User input means using visual displays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/04—Measuring blood pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/06—Measuring blood flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Clinical applications
- A61B8/0891—Clinical applications for diagnosis of blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/48—Diagnostic techniques
- A61B8/485—Diagnostic techniques involving measuring strain or elastic properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/022—Measuring pressure in heart or blood vessels by applying pressure to close blood vessels, e.g. against the skin; Ophthalmodynamometers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4887—Locating particular structures in or on the body
- A61B5/489—Blood vessels
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Physiology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Artificial Intelligence (AREA)
- Signal Processing (AREA)
- Psychiatry (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Urology & Nephrology (AREA)
- Evolutionary Computation (AREA)
- Fuzzy Systems (AREA)
- Mathematical Physics (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16170635 | 2016-05-20 | ||
| EP16170635.3 | 2016-05-20 | ||
| EP16176863.5 | 2016-06-29 | ||
| EP16176863 | 2016-06-29 | ||
| PCT/EP2017/062230 WO2017198871A1 (en) | 2016-05-20 | 2017-05-22 | Determining pulse wave velocity using intravascular pressure measurement and external ultrasound imaging, and associated devices, systems, and methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109152541A true CN109152541A (zh) | 2019-01-04 |
Family
ID=58873791
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201780031122.9A Pending CN109152541A (zh) | 2016-05-20 | 2017-05-22 | 使用脉管内压力测量和外部超声成像来确定脉搏波速度以及相关联的设备、系统和方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20190082978A1 (enExample) |
| EP (1) | EP3457928B1 (enExample) |
| JP (1) | JP6684929B2 (enExample) |
| CN (1) | CN109152541A (enExample) |
| WO (1) | WO2017198871A1 (enExample) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112932537A (zh) * | 2019-12-10 | 2021-06-11 | 深圳迈瑞生物医疗电子股份有限公司 | 一种超声成像设备、脉搏波成像方法 |
| WO2021114106A1 (zh) * | 2019-12-10 | 2021-06-17 | 深圳迈瑞生物医疗电子股份有限公司 | 一种超声成像设备和脉搏波成像方法 |
| CN113456942A (zh) * | 2021-08-16 | 2021-10-01 | 瑞安市人民医院 | 具有分段调节功能的icu用智能输液装置 |
| WO2022088478A1 (zh) * | 2020-10-26 | 2022-05-05 | 无锡祥生医疗科技股份有限公司 | 脉搏波速度的测量方法及超声设备 |
| WO2022141247A1 (zh) * | 2020-12-30 | 2022-07-07 | 深圳迈瑞生物医疗电子股份有限公司 | 超声成像设备和弹性参数的显示方法 |
| WO2022237233A1 (zh) * | 2021-05-13 | 2022-11-17 | 苏州润迈德医疗科技有限公司 | 用于内脏动脉去交感神经的消融方法、系统及存储介质 |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12465324B2 (en) | 2015-02-12 | 2025-11-11 | Foundry Innovation & Research 1, Ltd. | Patient fluid management systems and methods employing integrated fluid status sensing |
| CA2976465A1 (en) | 2015-02-12 | 2016-08-18 | Foundry Innovation & Research 1, Ltd. | Implantable devices and related methods for heart failure monitoring |
| US11039813B2 (en) | 2015-08-03 | 2021-06-22 | Foundry Innovation & Research 1, Ltd. | Devices and methods for measurement of Vena Cava dimensions, pressure and oxygen saturation |
| US11701018B2 (en) | 2016-08-11 | 2023-07-18 | Foundry Innovation & Research 1, Ltd. | Wireless resonant circuit and variable inductance vascular monitoring implants and anchoring structures therefore |
| EP3496606A1 (en) | 2016-08-11 | 2019-06-19 | Foundry Innovation & Research 1, Ltd. | Systems and methods for patient fluid management |
| US11206992B2 (en) | 2016-08-11 | 2021-12-28 | Foundry Innovation & Research 1, Ltd. | Wireless resonant circuit and variable inductance vascular monitoring implants and anchoring structures therefore |
| EP3705031B1 (en) | 2016-11-29 | 2025-12-10 | Foundry Innovation & Research 1, Ltd. | Wireless resonant circuit and variable inductance vascular implants for monitoring patient vasculature system |
| DE102016123846A1 (de) * | 2016-12-08 | 2018-06-14 | Visus Health It Gmbh | Detektorband für Röntgenfilm |
| CN110573089A (zh) * | 2017-03-31 | 2019-12-13 | 皇家飞利浦有限公司 | 血管内流动和压力测量结果 |
| WO2018220146A1 (en) | 2017-05-31 | 2018-12-06 | Foundry Innovation & Research 1, Ltd. | Implantable sensors for vascular monitoring |
| US11944495B2 (en) | 2017-05-31 | 2024-04-02 | Foundry Innovation & Research 1, Ltd. | Implantable ultrasonic vascular sensor |
| EP3613350A1 (en) | 2018-08-21 | 2020-02-26 | Koninklijke Philips N.V. | Systems and method for performing pulse wave velocity measurements |
| CN112955974B (zh) | 2018-10-26 | 2025-01-14 | 皇家飞利浦有限公司 | 用于确定肾脏去神经支配处置反应指数的设备、系统和方法 |
| US11918325B2 (en) | 2018-10-26 | 2024-03-05 | Koninklijke Philips N.V. | Pulse wave velocity measurement system |
| EP3714780A1 (en) | 2019-03-28 | 2020-09-30 | Koninklijke Philips N.V. | Pulse wave velocity measurement system |
| EP3643222A1 (en) * | 2018-10-26 | 2020-04-29 | Koninklijke Philips N.V. | Device and system for assessing reliability of vessel physiology related measurement |
| EP3952730A4 (en) * | 2019-04-12 | 2023-01-18 | Ulink Labs, Inc. | Systems, devices, and methods for wireless monitoring |
| USD926199S1 (en) | 2019-05-17 | 2021-07-27 | Opsens, Inc. | Display screen or portion thereof with graphical user interface |
| WO2021003735A1 (zh) * | 2019-07-11 | 2021-01-14 | 深圳迈瑞生物医疗电子股份有限公司 | 一种参数的检测方法以及参数检测系统 |
| EP4516237A3 (en) * | 2020-05-19 | 2025-04-16 | Coravie Medical, Inc. | Injectable hemodynamic monitoring systems |
| WO2023278612A1 (en) | 2021-06-29 | 2023-01-05 | Ulink Labs, Inc. | Systems, devices, and methods for establishing a wireless link in a heterogeneous medium |
| US20230270407A1 (en) * | 2022-02-26 | 2023-08-31 | Xenter, Inc. | Medical devices, systems, and methods incorporating the same |
| WO2024023791A1 (en) | 2022-07-29 | 2024-02-01 | Foundry Innovation & Research 1, Ltd. | Multistranded conductors adapted to dynamic in vivo environments |
| EP4637557A1 (en) * | 2023-01-10 | 2025-10-29 | Becton, Dickinson and Company | System and method for monitoring autoregulation |
Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991019451A1 (fr) * | 1990-06-19 | 1991-12-26 | Mitsuei Tomita | Dispositif de mesure de la vitesse et du volume du debit sanguin dans l'aorte |
| WO2000055579A2 (en) * | 1999-03-16 | 2000-09-21 | Florence Medical Ltd. | A system and method for detection and characterization of stenosis, blood vessels flow and vessel walls properties using vessel geometrical measurements |
| EP0898938B1 (en) * | 1997-09-01 | 2003-05-02 | Terumo Kabushiki Kaisha | Cardiovascular information measurement system |
| WO2003047418A2 (en) * | 2001-11-29 | 2003-06-12 | University Of Medicine And Dentistry Of New Jersey | A modified esophageal doppler monitor |
| WO2006023924A1 (en) * | 2004-08-23 | 2006-03-02 | Boston Scientific Limited | System for measuring pulse wave velocity with an intravascular device |
| US20060287600A1 (en) * | 2003-09-18 | 2006-12-21 | Mceowen Edwin L | Multiparameter whole blood monitor and method |
| CN101677810A (zh) * | 2007-06-04 | 2010-03-24 | 松下电器产业株式会社 | 超声波诊断装置及用于超声波诊断装置的超声波探头 |
| CN102413771A (zh) * | 2009-04-24 | 2012-04-11 | 株式会社日立医疗器械 | 超声波摄像装置 |
| US20140012133A1 (en) * | 2012-05-31 | 2014-01-09 | CardioSonic Ltd. | Method and/or apparatus for measuring renal denervation effectiveness |
| WO2014091999A1 (ja) * | 2012-12-11 | 2014-06-19 | 日立アロカメディカル株式会社 | 超音波撮像装置及び方法 |
| CN105392429A (zh) * | 2013-07-19 | 2016-03-09 | 火山公司 | 用于评价脉管的设备、系统和方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3668687B2 (ja) * | 2001-01-30 | 2005-07-06 | アロカ株式会社 | 脈波伝播速度計測装置及び超音波診断装置 |
| CN102869308B (zh) | 2010-05-03 | 2015-04-29 | 皇家飞利浦电子股份有限公司 | 用于对介入工具上的(一个或多个)超声换能器进行超声跟踪的设备和方法 |
-
2017
- 2017-05-22 JP JP2018560138A patent/JP6684929B2/ja not_active Expired - Fee Related
- 2017-05-22 WO PCT/EP2017/062230 patent/WO2017198871A1/en not_active Ceased
- 2017-05-22 CN CN201780031122.9A patent/CN109152541A/zh active Pending
- 2017-05-22 EP EP17726891.9A patent/EP3457928B1/en active Active
-
2018
- 2018-11-19 US US16/194,872 patent/US20190082978A1/en not_active Abandoned
Patent Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991019451A1 (fr) * | 1990-06-19 | 1991-12-26 | Mitsuei Tomita | Dispositif de mesure de la vitesse et du volume du debit sanguin dans l'aorte |
| EP0898938B1 (en) * | 1997-09-01 | 2003-05-02 | Terumo Kabushiki Kaisha | Cardiovascular information measurement system |
| WO2000055579A2 (en) * | 1999-03-16 | 2000-09-21 | Florence Medical Ltd. | A system and method for detection and characterization of stenosis, blood vessels flow and vessel walls properties using vessel geometrical measurements |
| WO2003047418A2 (en) * | 2001-11-29 | 2003-06-12 | University Of Medicine And Dentistry Of New Jersey | A modified esophageal doppler monitor |
| US20060287600A1 (en) * | 2003-09-18 | 2006-12-21 | Mceowen Edwin L | Multiparameter whole blood monitor and method |
| WO2006023924A1 (en) * | 2004-08-23 | 2006-03-02 | Boston Scientific Limited | System for measuring pulse wave velocity with an intravascular device |
| CN101677810A (zh) * | 2007-06-04 | 2010-03-24 | 松下电器产业株式会社 | 超声波诊断装置及用于超声波诊断装置的超声波探头 |
| CN102413771A (zh) * | 2009-04-24 | 2012-04-11 | 株式会社日立医疗器械 | 超声波摄像装置 |
| US20140012133A1 (en) * | 2012-05-31 | 2014-01-09 | CardioSonic Ltd. | Method and/or apparatus for measuring renal denervation effectiveness |
| WO2014091999A1 (ja) * | 2012-12-11 | 2014-06-19 | 日立アロカメディカル株式会社 | 超音波撮像装置及び方法 |
| CN105392429A (zh) * | 2013-07-19 | 2016-03-09 | 火山公司 | 用于评价脉管的设备、系统和方法 |
Non-Patent Citations (2)
| Title |
|---|
| 李佳月: "《脉搏波传导速度测定的临床意义》", 《国际心血管病杂志》 * |
| 杨宁，程康安，李拥军: "《去肾交感神经支配术与高血压》", 《介入放射学》 * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112932537A (zh) * | 2019-12-10 | 2021-06-11 | 深圳迈瑞生物医疗电子股份有限公司 | 一种超声成像设备、脉搏波成像方法 |
| WO2021114106A1 (zh) * | 2019-12-10 | 2021-06-17 | 深圳迈瑞生物医疗电子股份有限公司 | 一种超声成像设备和脉搏波成像方法 |
| WO2022088478A1 (zh) * | 2020-10-26 | 2022-05-05 | 无锡祥生医疗科技股份有限公司 | 脉搏波速度的测量方法及超声设备 |
| WO2022141247A1 (zh) * | 2020-12-30 | 2022-07-07 | 深圳迈瑞生物医疗电子股份有限公司 | 超声成像设备和弹性参数的显示方法 |
| WO2022237233A1 (zh) * | 2021-05-13 | 2022-11-17 | 苏州润迈德医疗科技有限公司 | 用于内脏动脉去交感神经的消融方法、系统及存储介质 |
| CN113456942A (zh) * | 2021-08-16 | 2021-10-01 | 瑞安市人民医院 | 具有分段调节功能的icu用智能输液装置 |
| CN113456942B (zh) * | 2021-08-16 | 2022-09-06 | 瑞安市人民医院 | 具有分段调节功能的icu用智能输液装置 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019518518A (ja) | 2019-07-04 |
| JP6684929B2 (ja) | 2020-04-22 |
| US20190082978A1 (en) | 2019-03-21 |
| EP3457928A1 (en) | 2019-03-27 |
| EP3457928B1 (en) | 2019-11-20 |
| WO2017198871A1 (en) | 2017-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109152541A (zh) | 使用脉管内压力测量和外部超声成像来确定脉搏波速度以及相关联的设备、系统和方法 | |
| CN109152538A (zh) | 用于基于血管内压力和横截面管腔测量的针对肾脏去神经支配的患者分层的设备和方法 | |
| JP4602972B2 (ja) | 超音波診断装置および超音波診断装置の制御方法 | |
| WO2017198867A1 (en) | Devices and methods for determining pulse wave velocity based on changes in vessel diameter | |
| US20240180523A1 (en) | A Portable Ultrasound Device and Method for Ultrasonic Imaging | |
| JP2022509401A (ja) | 管腔内超音波イメージングのためのグラフィカル長手方向表示、並びに、関連するデバイス、システム、及び方法 | |
| CN109152540A (zh) | 用于使用多个压力传感器来确定脉搏波速度的设备、系统和方法 | |
| US11701092B2 (en) | Automated ultrasound apparatus and methods to non-invasively monitor fluid responsiveness | |
| CN109152534A (zh) | 基于血管内压力和壁厚测量的用于针对肾脏去神经支配的患者分层的设备、系统和方法 | |
| US20140358038A1 (en) | Automatic monitoring for and detection of tissue pop | |
| WO2019135096A1 (en) | System for determining peripheral artery disease and method of use | |
| KR102489579B1 (ko) | 주석 관련 정보를 제공하는 방법 및 이를 위한 초음파 장치 | |
| EP3263018A1 (en) | Devices and methods for stratification of patients for renal denervation based on intravascular pressure and wall thickness measurements | |
| Sloves et al. | Venous diagnostic tools | |
| US20240285360A1 (en) | Systems and methods for supervised remote imaging-guided intervention | |
| Tamborini | A Novel Approach to Cardiac Health Assessment Using a Redesign of the Brachial Cuff Device | |
| Evans et al. | Ultrasound imaging for the surgical intensivist | |
| Salman et al. | Minimally Invasive and Non‐Invasive Sensor Technologies for Predicting Heart Failure: An Overview | |
| Centracchio et al. | A novel system to record pulses, thrills, and bruit sounds generated by arteriovenous fistulas | |
| JP6630980B2 (ja) | 健康管理装置及び健康管理方法 | |
| Samoylenko | Measuring the Effect of the Tail-cuff Protocol on Central Blood Pressure in the Mouse | |
| Superficial | ETIOLOGY AND NATURAL HISTORY OF DISEASE | |
| WO2020029255A1 (zh) | 人体多点机械振动参数随时间演进的混合测量方法与装置 | |
| TWM419548U (en) | Real-time body meridians detection system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190104 |